Cargando…
The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
Metformin-treated diabetics (MTD) showed a decrease in cobalamin, a rise in homocysteine, and methylmalonic acid, leading to accentuated diabetic peripheral neuropathy (DPN). This study aimed to determine whether or not metformin is a risk factor for DPN. We compared MTD to non-metformin-treated dia...
Autores principales: | Hashem, Manal Mohammed, Esmael, Ahmed, Nassar, Abdelfattah Kasem, El-Sherif, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820469/ https://www.ncbi.nlm.nih.gov/pubmed/33479439 http://dx.doi.org/10.1038/s41598-021-81631-8 |
Ejemplares similares
-
Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
por: Yang, Ruotong, et al.
Publicado: (2023) -
Correlation between Diabetic Retinopathy and Diabetic Peripheral Neuropathy in Patients with Type II Diabetes Mellitus
por: Hafeez, Mohammed, et al.
Publicado: (2022) -
The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus
por: Alharbi, Turki J., et al.
Publicado: (2018) -
Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
por: Ko, Seung-Hyun, et al.
Publicado: (2012) -
The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus
por: Xu, Tingting, et al.
Publicado: (2017)